Literature DB >> 10541965

Two stages of cancer prevention with green tea.

H Fujiki.   

Abstract

Cancer chemoprevention is a new and important medical science in its own right. On the occasion of my presentation entitled "Natural agents and cancer chemoprevention" at the 90th AACR Meeting in 1999, I summarized our recent results on cancer prevention with green tea. In this article, the present status of clinical trials supported by the Chemoprevention Branch of the National Cancer Institute in the United States is first described by way of introduction. Although various natural products are now under investigation in phase I clinical trials, green tea has, perhaps, the greatest potential for further development. In order to expand our understanding of the effects of tea polyphenols and green tea, I review their ability to inhibit growth and cause apoptosis of cancer cells, their distribution into target organs and their other cancer-preventing properties. In addition, the paper focuses on the significance of reducing tumor necrosis factor alpha (TNFalpha) gene expression in cells and TNFalpha release from cells as essential activities for cancer prevention. As for the amounts of green tea effective in cancer prevention, I present two results from our Research Institute: a prospective cohort study with over 8000 individuals in Saitama Prefecture revealed that the daily consumption of at least ten Japanese-size cups of green tea resulted in delayed cancer onset, and a follow-up study of breast cancer patients conducted at our Hospital found that stages I and II breast cancer patients consuming over five cups per day experienced a lower recurrence rate and longer disease-free period than those consuming fewer than four cups per day. Thus, I propose here, for the first time, the two-stage approach to analyzing cancer prevention with green tea: cancer prevention before cancer onset and cancer prevention following cancer treatment. As an additional example of cancer prevention with natural agents, kava, a daily beverage in Fiji, is mentioned. All the evidence reminds us of the significance of alternative medicine in practical cancer prevention.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541965     DOI: 10.1007/s004320050321

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

1.  Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population.

Authors:  Li-Na Mu; Qing-Yi Lu; Shun-Zhang Yu; Qing-Wu Jiang; Wei Cao; Nai-Chieh You; Veronica Wendy Setiawan; Xue-Fu Zhou; Bao-Guo Ding; Ru-Hong Wang; Jinkou Zhao; Lin Cai; Jian-Yu Rao; David Heber; Zuo-Feng Zhang
Journal:  Int J Cancer       Date:  2005-10-10       Impact factor: 7.396

2.  Expressed sequence tags from persimmon at different developmental stages.

Authors:  T Nakagawa; A Nakatsuka; K Yano; S Yasugahira; R Nakamura; N Sun; A Itai; T Suzuki; H Itamura
Journal:  Plant Cell Rep       Date:  2008-02-27       Impact factor: 4.570

3.  Producing low-caffeine tea through post-transcriptional silencing of caffeine synthase mRNA.

Authors:  Prashant Mohanpuria; Vinay Kumar; Paramvir Singh Ahuja; Sudesh Kumar Yadav
Journal:  Plant Mol Biol       Date:  2011-05-12       Impact factor: 4.076

4.  Computational modeling of the potential interactions of the proteasome beta5 subunit and catechol-O-methyltransferase-resistant EGCG analogs.

Authors:  Jyoti Kanwar; Imthiyaz Mohammad; Huanjie Yang; Congde Huo; Tak Hang Chan; Q Ping Dou
Journal:  Int J Mol Med       Date:  2010-08       Impact factor: 4.101

5.  Inhibition of catechol-Omicron-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG.

Authors:  Kristin Landis-Piwowar; Di Chen; Tak Hang Chan; Q Ping Dou
Journal:  Oncol Rep       Date:  2010-08       Impact factor: 3.906

Review 6.  Green tea polyphenols as a natural tumour cell proteasome inhibitor.

Authors:  Q P Dou; K R Landis-Piwowar; D Chen; C Huo; S B Wan; T H Chan
Journal:  Inflammopharmacology       Date:  2008-10       Impact factor: 4.473

7.  Antitumor activity of novel fluoro-substituted (-)-epigallocatechin-3-gallate analogs.

Authors:  Huanjie Yang; Dong Kui Sun; Di Chen; Qiuzhi Cindy Cui; Yan Yan Gu; Tao Jiang; Wei Chen; Sheng Biao Wan; Q Ping Dou
Journal:  Cancer Lett       Date:  2009-12-03       Impact factor: 8.679

8.  Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53.

Authors:  Yaxiong Tang; Anne R Simoneau; Jun Xie; Babbak Shahandeh; Xiaolin Zi
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

Review 9.  Multitargeted therapy of cancer by green tea polyphenols.

Authors:  Naghma Khan; Hasan Mukhtar
Journal:  Cancer Lett       Date:  2008-05-22       Impact factor: 8.679

10.  Prodrugs of fluoro-substituted benzoates of EGC as tumor cellular proteasome inhibitors and apoptosis inducers.

Authors:  Zhiyong Yu; Xu Long Qin; Yan Yan Gu; Di Chen; Qiuzhi Cindy Cui; Tao Jiang; Sheng Biao Wan; Q Ping Dou
Journal:  Int J Mol Sci       Date:  2008-06-02       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.